Evaluation of Progesterone and Ovulation-stimulating Drugs on the Glandular Epithelium and Angiogenesis in Mice

Document Type : Original Article

Authors

1 Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Anatomical Sciences and Molecular Biology, School of Medicine, Mashhad University of Medical Sciences, Mashhad; Department of Anatomical Sciences and Molecular Biology, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran

Abstract

Background: Human endometrium is a dynamic tissue during the menstrual cycle can be influenced by ovarian hormones. The purpose of this study was to evaluate the endometrium angiogenesis under the influence of human menopausal gonadotropin and human chorionic gonadotropin (HMG and HCG) that stimulate ovulation and progesterone. Materials and Methods: In this study, thirty adult female mice were randomly divided into three groups as: control, gonadotropin and gonadotropin + progesterone. The mice in the other two groups except the control group received 7.5 IU HMG and later HCG. Subsequently, the mice were placed in a cage for mating. Gonadotropin + progesterone group was administered, 1 mg/mouse progesterone in 24, 48, and 72 h interval, after HMG injection. Ninety-six hours after HMG injection, animals were sacrificed, and their uterine specimens were prepared by immunohistochemistry technique for light microscopic studies, and statistical analysis was carried out. Results: Endometrium angiogenesis in control group showed that mean ± standard deviation was 24.15 ± 11.15, gonadotropin group was 62.50 ± 24.16, and gonadotropin + progesterone group was 41.85 ± 19.54. Significant difference between the control group and gonadotropin group and between the control group and gonadotropin + progesterone was observed. Statistically significant differences were observed in all groups in the endometrial angiogenesis (P < 0.05). Conclusion: Ovarian induction with gonadotropins and gonadotropins + progesterone could not change the morphometrically index of endometrial glandular epithelium in mice. Ovarian stimulation followed by progesterone injection could modify the angiogenesis of mice endometrium.

Keywords

1.
Martínez-Conejero JA, Simón C, Pellicer A, Horcajadas JA. Is ovarian stimulation detrimental to the endometrium? Reprod Biomed Online 2007;15:45-50.  Back to cited text no. 1
    
2.
Wang H, Dey SK. Roadmap to embryo implantation: Clues from mouse models. Nat Rev Genet 2006;7:185-99.  Back to cited text no. 2
    
3.
Nikas G, Makrigiannakis A. Endometrial pinopodes and uterine receptivity. Ann N Y Acad Sci 2003;997:120-3.  Back to cited text no. 3
    
4.
Mulac-Jericevic B, Conneely OM. Reproductive tissue selective actions of progesterone receptors. Reproduction 2004;128:139-46.  Back to cited text no. 4
    
5.
Mercé LT, Barco MJ, Bau S, Troyano J. Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome? Fertil Steril 2008;89:111-7.  Back to cited text no. 5
    
6.
Zhang X, Chen CH, Confino E, Barnes R, Milad M, Kazer RR. Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer. Fertil Steril 2005;83:336-40.  Back to cited text no. 6
    
7.
Richter KS, Bugge KR, Bromer JG, Levy MJ. Relationship between endometrial thickness and embryo implantation, based on 1,294 cycles of in vitro fertilization with transfer of two blastocyst-stage embryos. Fertil Steril 2007;87:53-9.  Back to cited text no. 7
    
8.
Dorn C, Reinsberg J, Willeke C, Wendt A, van der Ven H, Schild RL. Three-dimensional power Doppler ultrasound of the subendometrial blood flow under the administration of a contrast agent (Levovist). Arch Gynecol Obstet 2004;270:94-8.  Back to cited text no. 8
    
9.
Al-Ghamdi A, Coskun S, Al-Hassan S, Al-Rejjal R, Awartani K. The correlation between endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome. Reprod Biol Endocrinol 2008;6:37.  Back to cited text no. 9
    
10.
Demir R, Seval Y, Huppertz B. Vasculogenesis and angiogenesis in the early human placenta. Acta Histochem 2007;109:257-65.  Back to cited text no. 10
    
11.
Al-Inany HG, Abou-Setta AM, Aboulghar MA, Mansour RT, Serour GI. Efficacy and safety of human menopausal gonadotrophins versus recombinant FSH: A meta-analysis. Reprod Biomed Online 2008;16:81-8.  Back to cited text no. 11
    
12.
Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997;18:657-65.  Back to cited text no. 12
    
13.
Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies. Cancer Res 2000;60:1388-93.  Back to cited text no. 13
    
14.
Arroyo JA, Winn VD, editors. Vasculogenesis and angiogenesis in the IUGR placenta. Semin Perinatol 2008;32:172-7.  Back to cited text no. 14
    
15.
Esmailzadeh S, Faramarzi M. Endometrial thickness and pregnancy outcome after intrauterine insemination. Fertil Steril 2007;88:432-7.  Back to cited text no. 15
    
16.
Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T, et al. Molecular cues to implantation. Endocr Rev 2004;25:341-73.  Back to cited text no. 16
    
17.
Franco JG Jr., Baruffi RL, Oliveira JB, Mauri AL, Petersen CG, Contart P, et al. Effects of recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-agonist protocol: A matched case-control study. Reprod Biol Endocrinol 2009;7:58.  Back to cited text no. 17
    
18.
Rogers PA, Polson D, Murphy CR, Hosie M, Susil B, Leoni M. Correlation of endometrial histology, morphometry, and ultrasound appearance after different stimulation protocols for in vitro fertilization. Fertil Steril 1991;55:583-7.  Back to cited text no. 18
    
19.
Macrow PJ, Li TC, Seif MW, Buckley CH, Elstein M. Endometrial structure after superovulation: A prospective controlled study. Fertil Steril 1994;61:696-9.  Back to cited text no. 19
    
20.
Bourlev V, Volkov N, Pavlovitch S, Lets N, Larsson A, Olovsson M. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction 2006;132:501-9.  Back to cited text no. 20
    
21.
Gambino LS, Wreford NG, Bertram JF, Dockery P, Lederman F, Rogers PA. Angiogenesis occurs by vessel elongation in proliferative phase human endometrium. Hum Reprod 2002;17:1199-206.  Back to cited text no. 21
    
22.
Gargett CE, Lederman FL, Lau TM, Taylor NH, Rogers PA. Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium. Hum Reprod 1999;14:2080-8.  Back to cited text no. 22
    
23.
Punyadeera C, Thijssen VL, Tchaikovski S, Kamps R, Delvoux B, Dunselman GA, et al. Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium. Mol Hum Reprod 2006;12:367-75.  Back to cited text no. 23
    
24.
Rogers PA, Au CL, Affandi B. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel. Hum Reprod 1993;8:1396-404.  Back to cited text no. 24
    
25.
Albrecht ED, Aberdeen GW, Niklaus AL, Babischkin JS, Suresch DL, Pepe GJ. Acute temporal regulation of vascular endothelial growth/permeability factor expression and endothelial morphology in the baboon endometrium by ovarian steroids. J Clin Endocrinol Metab 2003;88:2844-52.  Back to cited text no. 25
    
26.
Rashidi B, Rad JS, Roshangar L. Comparison of morphological and morphometrical characteristics in the glandular epithelium of mouse endometrium in preimplantation period after administration HMG-HCG, progesterone and sildenafil citrate. J Isfahan Med Sch 2010;28:(112).  Back to cited text no. 26
    
27.
Rashidi B, Rad JS, Roshangar L, Miran RA. Progesterone and ovarian stimulation control endometrial pinopode expression before implantation in mice. Pathophysiology 2012;19:131-5.  Back to cited text no. 27
    
28.
Rashidi B, Roshangar L, Soleimani RJ, Khaki A, Mohammadneghad D, Azami A. Comparison of morphology and morphometry of preimplantation mouse uterine endometrium in natural cycle with those received superovulatory drugs, progesterone and sildenafil citrate (Viagra). Pharmaceutical Sciences 2008; Autumn:33-9.  Back to cited text no. 28
    
29.
Sidell N, Feng Y, Hao L, Wu J, Yu J, Kane MA, et al. Retinoic acid is a cofactor for translational regulation of vascular endothelial growth factor in human endometrial stromal cells. Mol Endocrinol 2010;24:148-60.  Back to cited text no. 29
    
30.
Salehi E, Khazaei M, Rashidi B. Role of GW0742 a PPARβ/δ agonist on coronary angiogenesis in control and diabetic rats. J Isfahan Med Sch 2011;29(145).  Back to cited text no. 30
    
31.
Khazaei M, Salehi E, Rashidi B. Pan-PPAR agonist, bezafibrate, restores angiogenesis in hindlimb ischemia in normal and diabetic rats. Int J Pept 2012;2012:637212.  Back to cited text no. 31
    
32.
Licht P, Fluhr H, Neuwinger J, Wallwiener D, Wildt L. Is human chorionic gonadotropin directly involved in the regulation of human implantation? Mol Cell Endocrinol 2007;269:85-92.  Back to cited text no. 32
    
33.
Vasseur C, Rodien P, Beau I, Desroches A, Gérard C, de Poncheville L, et al. A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 2003;349:753-9.  Back to cited text no. 33
    
34.
Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008;21:9-23.  Back to cited text no. 34
    
35.
Krasnow JS, Berga SL, Guzick DS, Zeleznik AJ, Yeo KT. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: A preliminary report. Obstet Gynecol Surv 1996;51:423-5.  Back to cited text no. 35
    
36.
Hyder SM, Huang JC, Nawaz Z, Boettger-Tong H, Mäkelä S, Chiappetta C, et al. Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ Health Perspect 2000;108 Suppl 5:785-90.  Back to cited text no. 36
    
37.
Losordo DW, Isner JM. Estrogen and angiogenesis: A review. Arterioscler Thromb Vasc Biol 2001;21:6-12.  Back to cited text no. 37
    
38.
Kapiteijn K, Koolwijk P, van der Weiden RM, van Nieuw Amerongen G, Plaisier M, van Hinsbergh VW, et al. Human embryo-conditioned medium stimulates in vitro endometrial angiogenesis. Fertil Steril 2006;85:1232-9.  Back to cited text no. 38
    
39.
Kayisli UA, Luk J, Guzeloglu-Kayisli O, Seval Y, Demir R, Arici A. Regulation of angiogenic activity of human endometrial endothelial cells in culture by ovarian steroids. J Clin Endocrinol Metab 2004;89:5794-802.  Back to cited text no. 39